Showing results (11-20 of 83) with videos related to
Sort By:
Pageof 9
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 2, 2011
Transcriptional regulation of the chemokine co-receptor CCR5 by the cAMP/PKA/CREB pathwayAnupam Banerjee, Vanessa Pirrone, Brian Wigdahl, et al.Retrovirology|December 25, 2009
Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineageEvelyn M Kilareski, Sonia Shah, Michael R Nonnemacher, et al.Medical Microbiology and Immunology|March 6, 2019
Genetic variation and function of the HIV-1 Tat proteinCassandra Spector, Anthony R Mele, Brian Wigdahl, et al.The CRISPR Journal|April 26, 2019
Prediction of Human Immunodeficiency Virus Type 1 Subtype-Specific Off-Target Effects Arising from CRISPR-Cas9 Gene Editing TherapyRobert W Link, Michael R Nonnemacher, Brian Wigdahl, et al.Virus Research|June 14, 2012
Extracellular human immunodeficiency virus type 1 viral protein R causes reductions in astrocytic ATP and glutathione levels compromising the antioxidant reservoirAdriano Ferrucci, Michael R Nonnemacher, Eric A Cohen, et al.Journal of Neurovirology|April 9, 2016
Defining the roles for Vpr in HIV-1-associated neuropathogenesisTony James, Michael R Nonnemacher, Brian Wigdahl, et al.Advances in Virus Research|July 2, 2013
Genetic variation and HIV-associated neurologic diseaseSatinder Dahiya, Bryan P Irish, Michael R Nonnemacher, et al.Acta Neuropathologica Communications|March 14, 2023
Roles of neuropathology-associated reactive astrocytes: a systematic reviewJill M Lawrence, Kayla Schardien, Brian Wigdahl, et al.Current Opinion in HIV and AIDS|March 28, 2024
What's in a cure: designing a broad-spectrum HIV gene therapyRachel E Berman, Will Dampier, Michael R Nonnemacher, et al.Biomed Research International|January 29, 2015
Impact of viral activators and epigenetic regulators on HIV-1 LTRs containing naturally occurring single nucleotide polymorphismsSonia Shah, Vanessa Pirrone, Aikaterini Alexaki, et al.Pageof 9